Vanguard Group
KBIO

Vanguard Group’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-43,829
Closed 4239
2015
Q4
$0 Sell
43,829
-600
-1% ﹤0.01% 4283
2015
Q3
$85K Sell
44,429
-763,978
-95% -$1.46M ﹤0.01% 4110
2015
Q2
$388K Buy
808,407
+95,301
+13% +$45.7K ﹤0.01% 3930
2015
Q1
$349K Buy
713,106
+109,425
+18% +$53.6K ﹤0.01% 3911
2014
Q4
$1.04M Buy
603,681
+69,889
+13% +$121K ﹤0.01% 3522
2014
Q3
$827K Buy
533,792
+63,102
+13% +$97.8K ﹤0.01% 3563
2014
Q2
$1.07M Buy
470,690
+83,589
+22% +$191K ﹤0.01% 3465
2014
Q1
$1.05M Buy
387,101
+99,425
+35% +$269K ﹤0.01% 3444
2013
Q4
$1.27M Buy
287,676
+37,956
+15% +$168K ﹤0.01% 3346
2013
Q3
$1.13M Buy
249,720
+189,365
+314% +$856K ﹤0.01% 3334
2013
Q2
$342K Buy
+60,355
New +$342K ﹤0.01% 3559